Company: SYRA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009279
Chunk: 5

Company: Syra Health Corp
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 5
---
,447,050)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation 
     6,797  
     12,545 
  
    Common stock issued for services 
     2,586  
     18,875 
  
    Non-cash lease expense 
     -  
     31,373 
  
    Stock-based compensation, stock options 
     32,944  
     14,140 
  
    Changes in operating assets and liabilities: 

    Accounts receivable 
     (265,029) 
     314,951 
  
    Accounts receivable, related party 
     -  
     (31,510)
  
    Other current assets 
     65,775  
     7,900 
  
    Right-of-use asset 
     244,419  
     - 
  
    Accounts payable 
     223,337  
     182,576 
  
    Deferred revenue 
     582,602  
     6,108 
  
    Accrued expenses 
     (18,516) 
     120,720 
  
    Operating lease liability 
     (244,419) 
     (31,373)
  
    Net cash provided by/(used in) operating activities 
     158,231  
     (800,745)

    CASH FLOWS FROM INVESTING ACTIVITIES 

    Purchase of property and equipment 
     -  
     (5,619)
  
    Net cash used in investing activities 
     -  
     (5,619)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Proceeds received on exercise of warrants 
     14,800  
     850,129 
  
    Repayments on notes payable 
     (77,851) 
     (85,883)
  
    Net cash provided by/(used in) financing activities 
     (63,051) 
     764,246 

    NET CHANGE IN CASH AND CASH EQUIVALENTS 
     95,180  
     (42,118)
  
    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 
     2,395,405  
     3,280,075 
  
    CASH AND CASH